In the weeks to come I believe that BCRX will announce a number of international deals. Jon Stonhouse CEO of Bcrx has a pedigree and a lifelong involvement in Bio pharma - and be sure to know that by next year at this time - Bcrx will in all probability be bought out by a large pharmacutical company - well after FDA approval for peramivir. Shinogi, the Japanese drug company with liscensing rights from Bcrx has already applied for approval to sell the drug in Japan. Make no mistake about the essence of what Bcrx is bringing to market. If the numerous postings on this message board for a second think that you have ANY influence in derailing the company or stock price going forward you are sadly mistaken. Taking the laborious time to read many of the threads - it is fascinating to me how many of you (1) have been bashers of DNDN since last spring. You are the same individual(s) on this thread trying to accomplish in conjunction with Street.com - Cramer - A.F. and Biologic in trying to influence investors in selling their shares - well I'm here to let you all know that you have been 100% wrong on Dendreon and you are well into the process of being 100% wrong about Biocryst. Swine Flu is a world wide epidemic and for those of you who say the flu season is over - unfortuntaly it's full blown in some countries and only getting started in others. Our family has waited for months to get vacinated - and we have an asthmatic college age daughter who we are yet to get vacinated. So talk all your trash but the facts are those who are short and or betting against the importance of Bcrx as an onging and relevant company will be very disappointed. You should all only hope for the successe of Bcrx and the potential lives that peramivir can help save around the world. regards, Katonah